Abstract: For applications in the fields of organic electronics and photonics, disclosed are fluorescent charge-transfer compounds emitting in the visible spectral range from blue to red, including a triarylamine moiety, an electron-withdrawing group and at least two photopolymerizable groups. Also disclosed is a method for manufacturing a film-forming and photo-crosslinkable composition including at least one compound of the invention and its use as a precursor of a photocrosslinked emissive layer.

Abstract: A process for preparing a porous solid with an outer surface modified by at least one polymer; the polymer being simultaneously synthetized in solution and grafted on the outer surface of the solid, includes contacting: a porous solid; and a polymer-precursor solution comprising an adhesion primer, and at least one polymerizable monomer; under conditions enabling the formation of radical entities.

Abstract: The present invention relates to an implantable material having at least one external surface grafted with a film including carboxylate and sulfonate functions wherein the film is simultaneously synthesized and grafted directly on the external surface by radical reaction of a bifunctional adhesion primer of Formula (I) or by radical reaction of an adhesion primer and a bifunctional polymerizable monomer of Formula (II). The invention also relates to a process for directly synthesizing and grafting of a film according to the invention onto at least one external surface of an implantable material. The invention further relates to the use of a grafted implantable material for the manufacture of an antiproliferative and/or antibacterial implantable medical device. The invention also relates to compounds of Formula (I) and Formula (II).

Abstract: The present application is directed to a hydrophobic membrane assembly (28) used within a gas-generating apparatus. Hydrogen is separated from the reaction solution by passing through a hydrophobic membrane assembly (28) having a hydrophobic lattice like member (36) disposed within a hydrogen output composite (32) further enhancing the ability of the hydrogen output composite's ability to separate out hydrogen gas and prolonging its useful life.

Abstract: A fuel cell system (10) with a toggle switch (32) between an ON or OFF position is provided. In the OFF position, gas is purged from the fuel cell. The fuel cell (12) may surround the fuel source (14) with the cathode side of the fuel cell facing the fuel source. Additionally, both the fuel cell (12) and the fuel source (14) may have similar form factor to maximize the available space. Preferably the form factor is substantially an oval shape. The fuel cell system may also have a pressure regulator (26).

Abstract: A compact, reliable, and easily manufacture relief valve capable of resolving pressure issues within a fuel cell system and its components or devices. The relief valve comprises a valve body having a first cap, a valve housing and a center post; and an elastomeric member or sealing member contained within the valve body and being secured to the valve body at one end and forming a seal with the valve body at the other end. The seal opens in response to a threshold pressure being exceeded. In one embodiment, the elastomeric member is secured to the interior of the first cap and/or valve housing and forms a seal with the outer diameter of the center post. The elastomeric member may be supported by a reinforcing member.

Abstract: The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical compositions including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans, or an extract of Zostera marina or Lemna minor, including apiogalacturonans, or an extract of Caulerpa racemosa, including sulphated heteroglycans.

Abstract: The present application is directed to a hydrophobic membrane assembly (28) used within a gas-generating apparatus. Hydrogen is separated from the reaction solution by passing through a hydrophobic membrane assembly (28) having a hydrophobic lattice like member (36) disposed within a hydrogen output composite (32) further enhancing the ability of the hydrogen output composite's ability to separate out hydrogen gas and prolonging its useful life.

Abstract: The present application is directed to gas generators comprising a fuel mixture and a catalyst. The catalyst is contained in a self-regulated reactor or buoy, and selectively opens and closes to produce a gas in accordance with the demand for gas. This fuel mixture is generally a solution formed by dissolving a solid fuel component in a liquid fuel component. The mixing preferably occurs before the first use, and more preferably occurs immediately prior to the first use. The inventive gas generators preferably further comprises a starting mechanism that isolates the solid fuel from the liquid fuel or vice versa before the first use. In one embodiment, the starting mechanism further comprises a catalyst shield mechanism that isolates the catalyst in the reactor or buoy from the liquid and/or the solid fuel prior to the first use.

Abstract: The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical compositions including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans, or an extract of Zostera marina or Lemna minor, including apiogalacturonans, or an extract of Caulerpa racemosa, including sulphated heteroglycans.